Literature DB >> 29638031

Overrated hedonic judgment of odors in patients with schizophrenia.

Małgorzata Urban-Kowalczyk1, Janusz Śmigielski2, Magdalena Kotlicka-Antczak1.   

Abstract

AIMS: The odor identification ability and its hedonic judgment in patients with schizophrenia were evaluated in the study. The association between olfactory performance and negative symptoms and β-endorphin concentration was also analyzed.
METHODS: Study groups consisted of 23 patients with negative symptoms (PN) and 25 without predominant negative symptoms (PP) and 21 healthy individuals. The University of Pennsylvania Smell Identification Test, odor hedonic evaluation, and plasma concentrations of β-endorphin assay in all participants were performed.
RESULTS: PN perceived the poorer olfactory identification; nevertheless, they evaluated unpleasant odors as more pleasant than PP and controls. Beta-endorphin concentration was significantly higher among PN than in other study groups. No association was observed between β-endorphin and odors identification and odor hedonic judgment among all study groups.
CONCLUSIONS: There is potential relationship between increased β-endorphin concentration and severity of negative symptoms. Patients with predominant negative symptoms tend to evaluate odors as significantly more pleasant. Individuals with this subtype of schizophrenia might present specific, altered pattern of smell identification and hedonic judgment. Presumably, β-endorphin has no direct influence on olfactory identification performance and hedonic judgment in schizophrenia.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  endogenous opioids; negative symptoms; olfaction; pleasure; psychosis; schizophrenia

Mesh:

Substances:

Year:  2018        PMID: 29638031      PMCID: PMC6489818          DOI: 10.1111/cns.12849

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


  38 in total

Review 1.  Functional neuroimaging of the olfactory system in humans.

Authors:  D H Zald; J V Pardo
Journal:  Int J Psychophysiol       Date:  2000-05       Impact factor: 2.997

2.  Functional neuroanatomy of different olfactory judgments.

Authors:  J P Royet; J Hudry; D H Zald; D Godinot; M C Grégoire; F Lavenne; N Costes; A Holley
Journal:  Neuroimage       Date:  2001-03       Impact factor: 6.556

Review 3.  Endogenous morphine.

Authors:  G B Stefano; Y Goumon; F Casares; P Cadet; G L Fricchione; C Rialas; D Peter; D Sonetti; M Guarna; I D Welters; E Bianchi
Journal:  Trends Neurosci       Date:  2000-09       Impact factor: 13.837

4.  A ten-year longitudinal study of intense ambivalence as a predictor of risk for psychopathology.

Authors:  T R Kwapil; M L Raulin; J C Midthun
Journal:  J Nerv Ment Dis       Date:  2000-07       Impact factor: 2.254

5.  Effects of the opioid remifentanil on olfactory function in healthy volunteers.

Authors:  J Lötsch; J Darimont; C Skarke; M Zimmermann; T Hummel; G Geisslinger
Journal:  Life Sci       Date:  2001-09-28       Impact factor: 5.037

Review 6.  Olfactory dysfunction in schizophrenia: a qualitative and quantitative review.

Authors:  P J Moberg; R Agrin; R E Gur; R C Gur; B I Turetsky; R L Doty
Journal:  Neuropsychopharmacology       Date:  1999-09       Impact factor: 7.853

7.  Neural mechanisms of anhedonia in schizophrenia: a PET study of response to unpleasant and pleasant odors.

Authors:  B Crespo-Facorro; S Paradiso; N C Andreasen; D S O'Leary; G L Watkins; L L Ponto; R D Hichwa
Journal:  JAMA       Date:  2001-07-25       Impact factor: 56.272

Review 8.  Reward signaling by dopamine neurons.

Authors:  W Schultz
Journal:  Neuroscientist       Date:  2001-08       Impact factor: 7.519

9.  Ratings of different olfactory judgements in schizophrenia.

Authors:  Julie Hudry; Mohamed Saoud; Thierry D'Amato; Jean Daléry; Jean-Pierre Royet
Journal:  Chem Senses       Date:  2002-06       Impact factor: 3.160

10.  Olfaction and social drive in schizophrenia.

Authors:  Dolores Malaspina; Eliza Coleman
Journal:  Arch Gen Psychiatry       Date:  2003-06
View more
  5 in total

1.  Odor Identification Ability as a Mediator of Schizotypal Traits and Odor Hedonic Capacity in Non-Clinical Children and Adolescents.

Authors:  Ying Chen; Yuyang Zhan; Yiqi Qiu; Jiubo Zhao; Laiquan Zou
Journal:  Brain Sci       Date:  2022-04-22

2.  Nasal thallium-201 uptake in patients with parosmia with and without hyposmia after upper respiratory tract infection.

Authors:  Hideaki Shiga; Koichi Okuda; Junichi Taki; Naoto Watanabe; Hisao Tonami; Seigo Kinuya; Takaki Miwa
Journal:  Int Forum Allergy Rhinol       Date:  2019-07-29       Impact factor: 3.858

3.  The Relationship Between Course of Illness and β-Endorphin Plasma Levels in Patients with Schizophrenia.

Authors:  Małgorzata Urban-Kowalczyk; Magdalena Kotlicka-Antczak; Dominik Strzelecki; Ewa Rudecka; Janusz Śmigielski
Journal:  Neuropsychiatr Dis Treat       Date:  2019-12-31       Impact factor: 2.570

4.  Plasma β-Endorphin Concentration and Antipsychotic Treatment Outcome in Schizophrenia: 1-Year Follow-Up.

Authors:  Małgorzata Urban-Kowalczyk; Magdalena Kotlicka-Antczak; Dominik Strzelecki; Ewa Rudecka; Janusz Śmigielski
Journal:  Med Sci Monit       Date:  2020-09-06

5.  The Relationship Between Antipsychotic Treatment and Plasma β-Endorphin Concentration in Patients with Schizophrenia.

Authors:  Małgorzata Urban-Kowalczyk; Magdalena Kotlicka-Antczak; Dominik Strzelecki; Ewa Rudecka; Janusz Śmigielski
Journal:  Neuropsychiatr Dis Treat       Date:  2021-02-16       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.